These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 33552985)
1. Metabolic Syndrome and Risk of Upper Tract Urothelial Carcinoma: A Case-Control Study From Surveillance, Epidemiology and End Results-Medicare-Linked Database. Lu Y; Zhang W; Fan S; Liang Z; Li Z; Tian J; Kang J; Song Y; Liu K; Zhou K; Wang X; Yang Y; Liu X Front Oncol; 2020; 10():613366. PubMed ID: 33552985 [TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and upper tract urothelial carcinoma: A retrospective analysis from a large Chinese cohort. Xu H; Tan P; Zheng X; Ai J; Lin T; Jin X; Gong L; Lei H; Yang L; Wei Q Urol Oncol; 2019 Apr; 37(4):291.e19-291.e28. PubMed ID: 30584033 [TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data. Drahos J; Ricker W; Parsons R; Pfeiffer RM; Warren JL; Cook MB J Clin Gastroenterol; 2015 Apr; 49(4):282-8. PubMed ID: 24671095 [TBL] [Abstract][Full Text] [Related]
4. Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center. Dai X; Wang F; Du Y; Qin C; Lai S; Song Y; Huang Z; Han S; Zhang X; Xu T Front Oncol; 2022; 12():816915. PubMed ID: 35719953 [TBL] [Abstract][Full Text] [Related]
5. Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis. Peng FS; Wu WT; Zhang L; Shen JH; Yu DD; Mao LQ Front Oncol; 2022; 12():948289. PubMed ID: 36387214 [TBL] [Abstract][Full Text] [Related]
6. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807 [TBL] [Abstract][Full Text] [Related]
7. Secondary bladder cancer after upper tract urothelial carcinoma in the US population. Kates M; Badalato GM; Gupta M; McKiernan JM BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365 [TBL] [Abstract][Full Text] [Related]
8. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma. Collà Ruvolo C; Nocera L; Stolzenbach LF; Wenzel M; Cucchiara V; Tian Z; Shariat SF; Saad F; Longo N; Montorsi F; Briganti A; Mirone V; Karakiewicz PI Eur Urol Oncol; 2021 Oct; 4(5):792-801. PubMed ID: 33293235 [TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database. Lee HY; Tang JH; Chen YH; Wu WJ; Juan YS; Li WM; Chan TC Int J Clin Oncol; 2021 Mar; 26(3):569-577. PubMed ID: 33231793 [TBL] [Abstract][Full Text] [Related]
10. Association between Milk Consumption and Metabolic Syndrome among Korean Adults: Results from the Health Examinees Study. Shin S; Lee HW; Kim CE; Lim J; Lee JK; Kang D Nutrients; 2017 Oct; 9(10):. PubMed ID: 28991181 [TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data. Michels KA; McNeel TS; Trabert B Gynecol Oncol; 2019 Nov; 155(2):294-300. PubMed ID: 31495456 [TBL] [Abstract][Full Text] [Related]
12. Risk of metabolic syndrome for stroke is not greater than the sum of its components: Thai Epidemiologic Stroke (TES) study. Hanchaiphiboolkul S; Suwanwela NC; Poungvarin N; Nidhinandana S; Puthkhao P; Towanabut S; Tantirittisak T; Suwantamee J; Samsen M J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e264-70. PubMed ID: 22748714 [TBL] [Abstract][Full Text] [Related]
14. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study. Hsieh YH; Wu MF; Yang PY; Liao WC; Hsieh YH; Chang YJ; Lin IC BMC Gastroenterol; 2019 Feb; 19(1):33. PubMed ID: 30782138 [TBL] [Abstract][Full Text] [Related]
15. Trends in the utilization of imaging for upper tract urothelial carcinoma. Mohapatra A; Vemana G; Bhayani S; Baty J; Vetter J; Strope SA Urol Oncol; 2016 May; 34(5):236.e23-8. PubMed ID: 26803434 [TBL] [Abstract][Full Text] [Related]
16. The Prevalence and Prognostic Role of PD-L1 in Upper Tract Urothelial Carcinoma Patients Underwent Radical Nephroureterectomy: A Systematic Review and Meta-Analysis. Lu Y; Kang J; Luo Z; Song Y; Tian J; Li Z; Wang X; Liu L; Yang Y; Liu X Front Oncol; 2020; 10():1400. PubMed ID: 32974145 [No Abstract] [Full Text] [Related]
17. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data. Drahos J; Ricker W; Pfeiffer RM; Cook MB Cancer; 2017 Feb; 123(4):657-665. PubMed ID: 27861759 [TBL] [Abstract][Full Text] [Related]
18. Association Between Thyroid Nodules and Volume and Metabolic Syndrome in an Iodine-Adequate Area: A Large Community-Based Population Study. Su Y; Zhang YL; Zhao M; Zhang HQ; Zhang X; Guan QB; Yu CX; Shao SS; Xu J Metab Syndr Relat Disord; 2019 May; 17(4):217-222. PubMed ID: 30741593 [No Abstract] [Full Text] [Related]
19. Association between sleep duration and metabolic syndrome: a cross-sectional study. Kim CE; Shin S; Lee HW; Lim J; Lee JK; Shin A; Kang D BMC Public Health; 2018 Jun; 18(1):720. PubMed ID: 29895272 [TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome among overweight and obese adults in Palestinian refugee camps. Damiri B; Abualsoud MS; Samara AM; Salameh SK Diabetol Metab Syndr; 2018; 10():34. PubMed ID: 29713387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]